Work

Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-006-5934-5

Authors: Elisabeth I. Heath, Barbara A. Burtness, Lawrence Kleinberg, Ronald R. Salem, Stephen C. Yang, Richard F. Heitmiller, Marcia I. Canto, Jonathan P. S. Knisely, Mark Topazian, Elizabeth Montgomery, Nancy Tsottles, Yazdi Pithavala, Bridget Rohmiller, Mary Collier, Arlene A. Forastiere

Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, Yale Cancer Center, Yale University, Johns Hopkins University, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Pfizer (United States)

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2012089561

FWCI: 5.085

Cites: 22

Cited by: 44

Related to: 10